Because the SGLT2 inhibitors own anti-inflammatory and antioxidant abilities and demonstrates protective function on several of tissues 24, 30, we speculated that the usage of SGLT2 inhibitors may reduce the ocular inflammation and related corneal diseases. This evidence concerns the gene SLC5A2 and corneal disorder.